跳至主要内容
临床试验/NCT00691951
NCT00691951已完成3 期

Comparative Effects of Budesonide and Budesonide/Formoterol (Symbicort) on Asthma Control in Smoking Asthmatic Subjects: A Pilot Study

Laval University4 个研究点 分布在 1 个国家开始时间: 2008年6月6日最近更新:
适应症
相关药物

试验速览

阶段
3 期
状态
已完成
试验地点
4
主要终点
Comparative changes before and after treatments in each group for Asthma Control Questionnaire (ACQ)

研究概览

简要总结

A reduced response to inhaled corticosteroids (ICS) has been reported in smoking compared to non-smoking asthmatic patients. However, the comparative response to other currently prescribed medications such as combination therapy of long-acting beta agonists and ICS remain to be further evaluated.

No significant differences were found between our group of subjects in regard to changes in asthma control pulmonary function and airway inflammation following budesonide or the association of budesonide with formoterol for a period of 2 months. This should be further explored in larger groups of subjects.

研究设计

研究类型
Interventional

入排标准

年龄范围
18 Years 至 45 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • Asthmatic non-smokers or ex-smokers (less than 10 pack/years)
  • Asthmatic smokers (more than 5 cigarettes a day and more than 5 pack/years
  • FEV1 greater than 70%
  • No more than 3 doses of rescue medication (bronchodilator) per day

排除标准

  • Mentally or legally incapacitated thus preventing informed consent from being obtained
  • Other pulmonary disorder
  • History of upper respiratory tract infection in the last month
  • Pregnant or lactating women

结局指标

主要结局

Comparative changes before and after treatments in each group for Asthma Control Questionnaire (ACQ)

次要结局

  • Other control scores (ACSS score) and rescue B2 agonist need
  • Comparative changes in FEV1
  • Quality of life questionnaire
  • Morning and evening PEF
  • Total and differential cell counts in induced sputum and ECP and MPO

研究者

申办方类型
Other

研究点 (4)

Loading locations...

相似试验